USA Transplant Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Tissue Transplant, Organ Transplant, Living Donors, Deceased Donors), By Procedure (Autotransplantation, Allotransplantation, Xenotransplantation), By Product (Immunosuppresive Drugs, Preservation Solutions, Organ Transport Systems) – Forecast From 2019 To 2024

Published: Mar 2020 | Report Code:  KSI061612971 | Pages:  97

The USA Transplant market is projected to grow at a CAGR of 3.28% to reach a market size of US$ 40.295 billion by 2024, from US$33.205 billion in 2018. Transplants are also known as grafts or organ transplants where a section of a tissue or a complete organ from its original site is transferred to the area of interest in an individual (same or separate). Thus, the transplanted organ or graft continue to receive nourishment from the new and healthy environment. Prevalence of chronic diseases is one of the major factors driving the growth of the USA transplant market in the forecast period. Furthermore, growing health awareness along with government initiatives regarding organ donation is driving the market growth. However, the shortage of organ donors and incidences of transplant rejection may impede the growth of the USA transplant market during the forecast period. Additionally, technological advancements will drive market growth in the forecast period and in the upcoming years.

The “USA Transplant Market – Forecasts from 2019 to 2024” is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, procedure, and product.

The USA Transplant market on segmented based on type, procedure, and product. Based on type the market has been segmented into tissue transplant and organ transplant. Organ transplant is further segmented into living donors and deceased donors. By procedure, the market has been segmented into autotransplantation, allotransplantation, and xenotransplantation. By product, the market has been classified into immunosuppressive drugs, preservation solutions, and organ transport systems.

Major players in the USA transplant market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the USA transplant market.


The USA Transplant market has been analyzed through following segments:

By Type

Tissue Transplant

Organ Transplant

Living Donors

Deceased Donors

By Procedure




By Product

Immunosuppresive drugs

Preservation Solutions

Organ Transport Systems


Explore custom options available with this study:

  • Request customization

  • Buy sections of the study

  • Buy country specific report

  • Request excel, Historical data

  • Subscription inquiry

  • Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


We are in compliance with the global privacy laws.